| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |